世界の神経診断装置開発動向:医療機器パイプライン分析2015...市場調査レポートについてご紹介

【英文タイトル】Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 18
2 Introduction 19
2.1 Neurological Diagnostic Equipment Overview 19
3 Products under Development 20
3.1 Neurological Diagnostic Equipment – Pipeline Products by Stage of Development 20
3.2 Neurological Diagnostic Equipment – Pipeline Products by Segment 21
3.3 Neurological Diagnostic Equipment – Pipeline Products by Territory 22
3.4 Neurological Diagnostic Equipment – Pipeline Products by Regulatory Path 23
3.5 Neurological Diagnostic Equipment – Pipeline Products by Estimated Approval Date 24
3.6 Neurological Diagnostic Equipment – Ongoing Clinical Trials 25
4 Neurological Diagnostic Equipment – Pipeline Products under Development by Companies 26
4.1 Neurological Diagnostic Equipment Companies – Pipeline Products by Stage of Development 26
4.2 Neurological Diagnostic Equipment – Pipeline Products by Stage of Development 31
5 Neurological Diagnostic Equipment Companies and Product Overview 36
5.1 Acreo Swedish ICT AB Company Overview 36
5.1.1 Acreo Swedish ICT AB Pipeline Products & Ongoing Clinical Trials Overview 36
5.2 ADM Diagnostics, LLC Company Overview 37
5.2.1 ADM Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 Ad-Tech Medical Instrument Corporation Company Overview 38
5.3.1 Ad-Tech Medical Instrument Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.4 Advanced Brain Monitoring, Inc. Company Overview 39
5.4.1 Advanced Brain Monitoring, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.5 Advanced Diamond Technologies, Inc. Company Overview 41
5.5.1 Advanced Diamond Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.6 advanced neurometrics inc. Company Overview 42
5.6.1 advanced neurometrics inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Barron Associates, Inc. Company Overview 43
5.7.1 Barron Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 BioLert Electro Medical Systems Company Overview 45
5.8.1 BioLert Electro Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 45
5.9 Bio-Signal Group Corp. Company Overview 46
5.9.1 Bio-Signal Group Corp. Pipeline Products & Ongoing Clinical Trials Overview 46
5.10 BioSignostix Inc. Company Overview 48
5.10.1 BioSignostix Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 BiReme Pty Ltd Company Overview 49
5.11.1 BiReme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Brain Sentinel Company Overview 50
5.12.1 Brain Sentinel Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 BrainCare OY Company Overview 53
5.13.1 BrainCare OY Pipeline Products & Ongoing Clinical Trials Overview 53
5.14 Brainchem, LLC Company Overview 54
5.14.1 Brainchem, LLC Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 BrainScope Company, Inc. Company Overview 56
5.15.1 BrainScope Company, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.16 Braintech Ltd. Company Overview 65
5.16.1 Braintech Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
5.17 Cerora, Inc. Company Overview 66
5.17.1 Cerora, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.18 Children’s Hospital & Research Center Oakland Company Overview 67
5.18.1 Children’s Hospital & Research Center Oakland Pipeline Products & Ongoing Clinical Trials Overview 67
5.19 Cleveland Medical Devices, Inc. Company Overview 69
5.19.1 Cleveland Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
5.20 Cognionics, Inc. Company Overview 71
5.20.1 Cognionics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.21 Cognitive Sensing Inc. Company Overview 72
5.21.1 Cognitive Sensing Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.22 Columbia University Medical Center Company Overview 73
5.22.1 Columbia University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 73
5.23 Converge Medical, Inc Company Overview 74
5.23.1 Converge Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.24 Convergence Medical Devices Company Overview 75
5.24.1 Convergence Medical Devices Pipeline Products & Ongoing Clinical Trials Overview 75
5.25 Cortec GmbH Company Overview 76
5.25.1 Cortec GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
5.26 Cyberonics, Inc. Company Overview 78
5.26.1 Cyberonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.27 Dartmouth College Company Overview 80
5.27.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 80
5.28 DMetrix, Inc. Company Overview 81
5.28.1 DMetrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.29 Drexel University Company Overview 83
5.29.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 83
5.30 EIC Laboratories, Inc. Company Overview 84
5.30.1 EIC Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
5.31 Electrical Geodesics, Inc. Company Overview 85
5.31.1 Electrical Geodesics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.32 ElMinda Ltd. Company Overview 92
5.32.1 ElMinda Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.33 Epitel, Inc. Company Overview 101
5.33.1 Epitel, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Exploit Technologies Pte Ltd Company Overview 102
5.34.1 Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 Flint Hills Scientific, LLC Company Overview 104
5.35.1 Flint Hills Scientific, LLC Pipeline Products & Ongoing Clinical Trials Overview 104
5.36 Greatbatch, Inc. Company Overview 106
5.36.1 Greatbatch, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.37 HeadSense Medical Ltd. Company Overview 109
5.37.1 HeadSense Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 109
5.38 HEARD Medical Company Overview 112
5.38.1 HEARD Medical Pipeline Products & Ongoing Clinical Trials Overview 112
5.39 Henry Ford Health System Company Overview 113
5.39.1 Henry Ford Health System Pipeline Products & Ongoing Clinical Trials Overview 113
5.40 i360medical Limited Company Overview 115
5.40.1 i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview 115
5.41 IMEC Company Overview 116
5.41.1 IMEC Pipeline Products & Ongoing Clinical Trials Overview 116
5.42 Imperial College London Company Overview 117
5.42.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 117
5.43 Incereb Medical Ltd. Company Overview 119
5.43.1 Incereb Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 119
5.44 Infinite Biomedical Technologies, LLC Company Overview 121
5.44.1 Infinite Biomedical Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 121
5.45 InfraScan, Inc. Company Overview 123
5.45.1 InfraScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.46 Integra LifeSciences Holdings Corporation Company Overview 125
5.46.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 125
5.47 Integrated Sensing Systems, Inc. Company Overview 127
5.47.1 Integrated Sensing Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Jan Medical, Inc. Company Overview 129
5.48.1 Jan Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.49 KeepAlive Medical Ltd Company Overview 133
5.49.1 KeepAlive Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 133
5.50 Koronis Biomedical Technologies Corporation Company Overview 134
5.50.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 134
5.51 Lara Diagnostics AB Company Overview 135
5.51.1 Lara Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 135
5.52 Leap Medical Inc. Company Overview 136
5.52.1 Leap Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.53 Massachusetts Institute of Technology Company Overview 137
5.53.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 137
5.54 McGill University Company Overview 139
5.54.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 139
5.55 Medfield Diagnostics AB Company Overview 141
5.55.1 Medfield Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 141
5.56 Medisens Wireless, Inc. Company Overview 145
5.56.1 Medisens Wireless, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145
5.57 Mindful Scientific Inc. Company Overview 147
5.57.1 Mindful Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.58 Neba Health, LLC Company Overview 148
5.58.1 Neba Health, LLC Pipeline Products & Ongoing Clinical Trials Overview 148
5.59 Neural Analytics, Inc. Company Overview 150
5.59.1 Neural Analytics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.60 Neural Diagnostics Pty Ltd Company Overview 151
5.60.1 Neural Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 151
5.61 Neuro Assessment Systems Company Overview 155
5.61.1 Neuro Assessment Systems Pipeline Products & Ongoing Clinical Trials Overview 155
5.62 Neuro Devices, Inc. Company Overview 157
5.62.1 Neuro Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.63 Neuro Kinetics, Inc. Company Overview 159
5.63.1 Neuro Kinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 159
5.64 NeuroDx Development LLC Company Overview 161
5.64.1 NeuroDx Development LLC Pipeline Products & Ongoing Clinical Trials Overview 161
5.65 NeuroInDx, Inc. Company Overview 162
5.65.1 NeuroInDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
5.66 Neurokeeper Technologies Company Overview 163
5.66.1 Neurokeeper Technologies Pipeline Products & Ongoing Clinical Trials Overview 163
5.67 NeuroMetrix, Inc. Company Overview 166
5.67.1 NeuroMetrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.68 NeuroVigil, Inc. Company Overview 169
5.68.1 NeuroVigil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 169
5.69 NeuroWave Systems Inc. Company Overview 171
5.69.1 NeuroWave Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.70 NexGen Medical Systems, Inc. Company Overview 174
5.70.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 174
5.71 North Carolina State University Company Overview 175
5.71.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 175
5.72 Northwestern University Company Overview 177
5.72.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 177
5.73 NovoView Diagnostics LLC Company Overview 178
5.73.1 NovoView Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 178
5.74 Oculogica Inc. Company Overview 179
5.74.1 Oculogica Inc. Pipeline Products & Ongoing Clinical Trials Overview 179
5.75 Optima Neuroscience, Inc. Company Overview 180
5.75.1 Optima Neuroscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 180
5.76 Orsan Medical Technologies Ltd. Company Overview 181
5.76.1 Orsan Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 181
5.77 QUASAR, Inc. Company Overview 182
5.77.1 QUASAR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
5.78 ReHaptix GmbH Company Overview 183
5.78.1 ReHaptix GmbH Pipeline Products & Ongoing Clinical Trials Overview 183
5.79 SensoDetect AB Company Overview 184
5.79.1 SensoDetect AB Pipeline Products & Ongoing Clinical Trials Overview 184
5.80 SFC Fluidics LLC Company Overview 188
5.80.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 188
5.81 Smart Monitor Company Overview 189
5.81.1 Smart Monitor Pipeline Products & Ongoing Clinical Trials Overview 189
5.82 SoNovum AG Company Overview 190
5.82.1 SoNovum AG Pipeline Products & Ongoing Clinical Trials Overview 190
5.83 Southeast TechInventures, Inc. Company Overview 191
5.83.1 Southeast TechInventures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 191
5.84 Spectros Corporation Company Overview 192
5.84.1 Spectros Corporation Pipeline Products & Ongoing Clinical Trials Overview 192
5.85 Spire Corporation Company Overview 193
5.85.1 Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 Stanford University Company Overview 194
5.86.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 Swansea University Company Overview 195
5.87.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 195
5.88 Swiss Federal Institute of Technology Zurich Company Overview 196
5.88.1 Swiss Federal Institute of Technology Zurich Pipeline Products & Ongoing Clinical Trials Overview 196
5.89 Tel Aviv University Company Overview 198
5.89.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 198
5.90 The Feinstein Institute for Medical Research Company Overview 199
5.90.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 199
5.91 The Tel Aviv Sourasky Medical Center Company Overview 201
5.91.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 201
5.92 The University of Queensland Company Overview 202
5.92.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 202
5.93 Third Eye Diagnostics, Inc. Company Overview 203
5.93.1 Third Eye Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.94 Tristan Technologies, Inc. Company Overview 204
5.94.1 Tristan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 204
5.95 University College Cork Company Overview 206
5.95.1 University College Cork Pipeline Products & Ongoing Clinical Trials Overview 206
5.96 University of California, Berkeley Company Overview 207
5.96.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 207
5.97 University of California, Los Angeles Company Overview 209
5.97.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 209
5.98 University of California, San Diego Company Overview 210
5.98.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 210
5.99 University of Cambridge Company Overview 214
5.99.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 214
5.100 University of Cantabria Company Overview 216
5.100.1 University of Cantabria Pipeline Products & Ongoing Clinical Trials Overview 216
5.101 University of Canterbury Company Overview 217
5.101.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview 217
5.102 University of Cincinnati Company Overview 218
5.102.1 University of Cincinnati Pipeline Products & Ongoing Clinical Trials Overview 218
5.103 University of Colorado Company Overview 220
5.103.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 220
5.104 University of Florida Company Overview 222
5.104.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 222
5.105 University of Hertfordshire Company Overview 225
5.105.1 University of Hertfordshire Pipeline Products & Ongoing Clinical Trials Overview 225
5.106 University of Illinois Company Overview 226
5.106.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 226
5.107 University of Michigan Company Overview 227
5.107.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 227
5.108 University of Pennsylvania Company Overview 230
5.108.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 230
5.109 VisionQuest Biomedical, LLC Company Overview 232
5.109.1 VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 232
5.110 Vittamed Corporation Company Overview 234
5.110.1 Vittamed Corporation Pipeline Products & Ongoing Clinical Trials Overview 234
5.111 Vivonics, Inc. Company Overview 236
5.111.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 236
5.112 Washington and Lee University Company Overview 237
5.112.1 Washington and Lee University Pipeline Products & Ongoing Clinical Trials Overview 237
5.113 Wisconsin Institute of Nuclear Systems Company Overview 238
5.113.1 Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 238
6 Neurological Diagnostic Equipment- Recent Developments 240
7 Appendix 263
7.1 Methodology 263
7.2 About GlobalData 265
7.3 Contact Us 266
7.4 Disclaimer 266


【レポート販売概要】

■ タイトル:世界の神経診断装置開発動向:医療機器パイプライン分析2015
■ 英文:Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2015
■ 発行日:2016年1月5日
■ 調査会社:GlobalData
■ 商品コード:GDME0146EPD
■ 調査対象地域:グローバル
  • ココアの世界市場:ココア液、ココア粉、ココアバター
    About Cocoa Cocoa is cultivated primarily in countries located in the belt between 10ºN and 10ºS of the equator on account of the favorable climatic conditions. The demand for cocoa is increasing rapidly with the growth of chocolate confectioneries and other end-products. Cocoa production is characterized by the presence of small-scale farmers who have limited access to finance and technology, as …
  • LiDARの世界市場予測(~2023年)
    “The LiDAR market is estimated to grow at a CAGR of 17.2% between 2018 and 2023” The overall LiDAR market is expected to reach USD 1,809.5 million by 2023 from USD 819.1 million by 2018, at a CAGR of 17.2% between 2018 and 2023. The increasing use of drones equipped with LiDAR for greater accuracy in surveying applications and the introduction of technologically enhanced LiDAR are the key factors …
  • VRカードボードの世界市場2015-2019
    About VR cardboard VR cardboard which is also known by terms such as Google Cardboard and VR headsets are devices that act as a mount for smartphones and tablets. It is a platform developed by Google that provides downloadable instructions to individuals and manufacturers for building VR headsets. The name suggests that the headset can be built out of cardboard, but does not necessarily mean that …
  • プリンテッドバッテリーの世界市場2015-2019
    About Printed Batteries Printed electronics are created using various printing techniques, such as screen printing, flexography, gravure, offset lithography, and inkjet, on a substrate. This revolutionary method has helped create low cost, flexible, and eco-friendly electronics. Printed batteries are one of the products of printed electronics. They are thin, flat, and highly flexible. They are cur …
  • 外科用開創器の世界市場予測(~2023年)
    “The surgical retractors market is projected to grow at a CAGR of XX% during the forecast period”The global surgical retractors market is projected to reach USD 2.5 billion by 2023 from USD 1.8 billion in 2018, at a CAGR of 7.2%. The growth of this market is largely driven by factors such as the increasing number of surgical procedures; growing availability of specialized and application specific …
  • 動脈瘤コイリング及び塞栓装置の世界市場2019-2023
    About this market Technological advances in aneurysm coiling and embolization devices are likely to foster the market growth in the upcoming years. Innovative devices with novel designs and concepts are expected to ensure device delivery, thrombogenicity, safety, and occlusion durability. This has further led to the development of multi-dimensional, biologically inert, complex-shaped, soft, and st …
  • こめ油の世界市場2017-2021
    About Rice Bran OilRice bran oil is an edible oil extracted from rice's outer brown layer, which is known as rice bran. It contains 15%-20% oil by weight. Technavio’s analysts forecast the global rice bran oil market to grow at a CAGR of 5.14% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global rice bran oil market for …
  • グルコース及びマルトデキストリンの世界市場:グルコースシロップ、デキストロース、マルトデキストリン
    Today, change in lifestyles of people across the world and the increasing urbanization demand for more processed and convenience foods. Processed foods use starch in sophisticated systems; this in turn is expected to fuel the demand for starch and its derivatives in the coming years. Starch derivatives such as glucose and maltodextrin are used in various food products, such as instant desserts, pr …
  • 脂肪アルコールの国際貿易動向
    This report examines international trade and worldwide market trends pertaining to fatty alcohols. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on fatty alcohols export/import operations segmented by country and region. The report covers the 2007-2012 period, with mor …
  • 3Dプリント複合材料の世界市場2019-2023
    About this market The increasing adoption of additive manufacturing will trigger the market’s growth in the forthcoming years. 3D printed composites are increasingly being used as raw materials in additive manufacturing. Vendors are also using additive manufacturing for offering products catering in different end-user industries including aerospace, automotive, and medical devices manufacturing in …
  • 世界の自動車診断用スキャンツール市場(2014-2018)
    About Automotive Diagnostic Scan Tools Today, electronic systems in vehicles have become much more advanced, making it easier to identify any damages. In the past, the electronic systems had their own procedures, where a large number of different tools were used to analyse a single vehicle. This procedure was also done manually which was tiresome and time consuming. To overcome this, the garage eq …
  • 世界の製造実行システム市場:提供別(ソフトウェア、サービス)、展開別(オンプレミス、オンデマンド、ハイブリッド)、プロセス産業別(食品および飲料、医薬品および生命科学)、ディスクリート産業別、地域別
    “Manufacturing execution system market to grow at a CAGR of 14.3% from 2019 to 2024” The manufacturing execution system market is expected to grow from USD 11.8 billion by 2019 to USD 23.0 billion by 2024 at a CAGR of 14.3% from 2019 to 2024. A few key factors driving the growth of this market include increasing use of industrial automation in process and discrete industries, growing importance of …
  • 世界の核画像装置(医療機器)市場:企業動向
    MediPoint: Nuclear Imaging - Current and Future Players Summary This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand …
  • 洗濯用オーガニック洗剤の世界市場2016-2020
    Technavio research analyst predicts the global organic laundry detergents market to grow steadily at a CAGR of approximately 4% by 2020. The absence of phthalates, synthetic fragrances, artificial dyes, or colors in organic detergents is a significant factor that augments its adoption during the predicted period. Decreasing infant mortality rate is the key driver for the growth of this market. Org …
  • 新生児発作治療のグローバル臨床試験動向(2014年H2)
    Neonatal Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Seizures. It includes an overview of the trial numbers and their recruitment s …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。